Envoyer ce communique par e-mail
Aelis Farma Announces the Inclusion of the 1st Patient in a Phase 2b Study of AEF0117 for the Treatment of Cannabis Use Disorder (CUD)
*
Marquer les champs requis
Nom du destinataire:
*
Adresse e-mail du destinataire:
Message:
*
Enter security words: